| 今开：4.99 | 昨收：5.05 |
| 最高：5.05 | 最低：4.905 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.20319454E8 |
Allogene疗法(ALLO)2022-03-10 07:33
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-22-003836 Size: 6 KB 网页链接查看全文
chuminhua2020-12-16 12:33
12月15日，加利福尼亚州南旧金山，波士顿和中国上海，临床阶段生物技术公司Allogene Therapeutics，Inc.（纳斯达克股票代码：ALLO），是同种异体CAR T（AlloCAR T™）开发癌症疗法的临床阶段生物技术公司，以及由高瓴资本支持的瓴路药业（Overland）宣布成立Allogene Overland Biopharm（Allogen...查看全文
青侨阳光2020-11-04 07:18
回复@生活不是眼前的苟且: 您这个问题很有意思，我们探讨下哈~我们之前有篇《CART进入2.0，对中国是机遇 - 高瓴健康峰会（二）》的文章，里面有ALLO-501的临床数据。ALLO-501是Allogene（ALLO.O）从Cellectis（CLLS.O）引起的基于TALEN技术基因编辑的通用CART，疗效相仿的同时，安全性和便利性极大...查看全文
Allogene疗法(ALLO)2022-02-24 05:18
$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-22-000013 Act: 34 Size: 13 MB 网页链接查看全文
Allogene疗法(ALLO)2022-02-24 05:27
$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-22-000015 Act: 33 Size: 121 KB 网页链接查看全文
Allogene疗法(ALLO)2022-02-24 05:12
$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-22-000012 Act: 34 Size: 260 KB 网页链接查看全文
Allogene疗法(ALLO)2022-02-11 05:57
$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001123292-22-000014 Act: 34 Size: 171 KB 网页链接查看全文
Allogene疗法(ALLO)2022-02-15 06:57
$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-042233 Act: 34 Size: 33 KB 网页链接查看全文
Allogene疗法(ALLO)2022-02-12 00:33
$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001562230-22-000071 Act: 34 Size: 18 KB 网页链接查看全文
Allogene疗法(ALLO)2022-02-15 04:42
$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-041459 Act: 34 Size: 97 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 05:36
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 05:12
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 04:57
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 04:51
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接查看全文
Allogene疗法(ALLO)03-11 05:06
$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接查看全文
Allogene疗法(ALLO)03-01 05:36
$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-23-000020 Act: 33 Size: 133 KB 网页链接查看全文
Allogene疗法(ALLO)03-01 05:27
$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-23-000018 Act: 34 Size: 12 MB 网页链接查看全文
Allogene疗法(ALLO)03-01 05:12
$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-23-000017 Act: 34 Size: 267 KB 网页链接查看全文
Allogene疗法(ALLO)02-15 06:18
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000317 Size: 4 KB 网页链接查看全文
Allogene疗法(ALLO)02-14 05:36
$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035914 Act: 34 Size: 93 KB 网页链接查看全文
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接
$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接
$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-23-000020 Act: 33 Size: 133 KB 网页链接
$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-23-000018 Act: 34 Size: 12 MB 网页链接
$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-23-000017 Act: 34 Size: 267 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000317 Size: 4 KB 网页链接
$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035914 Act: 34 Size: 93 KB 网页链接